Ignite Creation Date:
2025-12-25 @ 1:06 AM
Ignite Modification Date:
2026-03-02 @ 3:43 PM
Study NCT ID:
NCT05417893
Status:
NOT_YET_RECRUITING
Last Update Posted:
2022-06-14
First Post:
2022-03-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Non-inferiority Clinical Trial to Compare the Safety and Performance of MeRes100 Sirolimus-eluting BioResorbable Vascular Scaffold System Versus Contemporary DES Platforms in Patients With de Novo Coronary Artery Lesions
Sponsor:
Meril Life Sciences Pvt. Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
MLS/MER/MeRethon RCT
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None